Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 076643

Expand all

CARBILEV (CARBIDOPA; LEVODOPA)
10MG;100MG
Marketing Status: Discontinued

Active Ingredient: CARBIDOPA; LEVODOPA
Proprietary Name: CARBILEV
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: 10MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076643
Product Number: 001
Approval Date: Jun 10, 2005
Applicant Holder Full Name: RANBAXY LABORATORIES LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

CARBILEV (CARBIDOPA; LEVODOPA)
25MG;100MG
Marketing Status: Discontinued

Active Ingredient: CARBIDOPA; LEVODOPA
Proprietary Name: CARBILEV
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: 25MG;100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076643
Product Number: 002
Approval Date: Jun 10, 2005
Applicant Holder Full Name: RANBAXY LABORATORIES LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information

CARBILEV (CARBIDOPA; LEVODOPA)
25MG;250MG
Marketing Status: Discontinued

Active Ingredient: CARBIDOPA; LEVODOPA
Proprietary Name: CARBILEV
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: 25MG;250MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076643
Product Number: 003
Approval Date: Jun 10, 2005
Applicant Holder Full Name: RANBAXY LABORATORIES LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information